publicações selecionadas
- Blood gene expression changes after Risperidone treatment in an antipsychotic-naïve cohort of first episode of psychosis patients
- Clozapine prescription trends in Brazil in the last decade
- Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia
- Aging biological markers in a cohort of antipsychotic-naïve first-episode psychosis patients
- A study in first-episode psychosis patients: does angiotensin I-converting enzyme (ACE) activity associated with genotype predict symptoms severity reductions after treatment with the atypical antipsychotic risperidone?
- COVID-19 pandemic and distinct patterns of psychotic outbreaks
- MARCADORES BIOLÓGICOS NA ESQUIZOFRENIA
- Biomarcadores periféricos nos transtornos psicóticos: a influência de características clínicas, estágio da doença e tratamento.
- BRIEF REPORTS UNRAVEILING THE CORRELATION AMONG NEURODEVELOPMENTAL AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA
- Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels
- LINE-1 hypomethylation is associated with poor risperidone response in a first episode of psychosis cohort
- Clozapine-induced hepatotoxicity: A life threatening situation
- Is treatment-resistant schizophrenia associated with distinct neurobiological callosal connectivity abnormalities?
- Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
- Patients with Schizophrenia Undergoing Gastric Bypass Surgery: a Case Series Study
- Fator neurotrófico Derivado do Cérebro e Citocinas Inflamatórias na Esquizofrenia
- Longitudinal invariance of the positive and negative syndrome scale negative dimension in antipsychotic naïve first-episode schizophrenia
- A symptom combination predicting treatment-resistant schizophrenia - A strategy for real-world clinical practice
- BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system
- COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey
- First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection
- Esketamine for Postpartum Suicidality
- Systems-Level Analysis of Genetic Variants Reveals Functional and Spatiotemporal Context in Treatment-resistant Schizophrenia
- Differences of affective and non-affective psychoses in early intervention services from Latin America
- Structural brain abnormalities in schizophrenia in adverse environments: examining the effect of poverty and violence in six Latin American cities
